Effect of lipid excipients on in vitro pancreatic lipase activity

Drug Development and Industrial Pharmacy

Volumn 29, Issue 8, 2003, Pages 885-890

  Subramanian, Ramaswamy ^a   Wasan, Kishor M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Gelucire 44 14; Oral formulations; Pancreatic lipase activity; Peceol

Indexed keywords

CHLOROFORM; COLIPASE; EXCIPIENT; FATTY ACID; GELUCIRE 44/14; HEPTANE; LIPID; METHANOL; PECEOL; SODIUM CARBONATE; TRIACYLGLYCEROL LIPASE;

AQUEOUS SOLUTION; ARTICLE; CENTRIFUGATION; CHEMICAL REACTION; CONCENTRATION RESPONSE; DRUG FORMULATION; DRUG MANUFACTURE; ENZYME ACTIVITY; EXTRACTION; IN VITRO STUDY; ORAL DRUG ADMINISTRATION; RADIOACTIVITY; REACTION ANALYSIS; ROOM TEMPERATURE; SCINTILLATION COUNTING;

EXCIPIENTS; LIPASE; LIPIDS; OLEIC ACIDS; PANCREAS; POLYETHYLENE GLYCOLS; TRIGLYCERIDES;

EID: 0141680636     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120024184     Document Type: Article

References (13)

1. Pouton, C.W.; Charman, W.N. The potential of oily formulations for drug delivery to the gastrointestinal tract. Adv. Drug Delivery Rev. 1997, 25, 1-2.
2. Porter, C.J.; Charman, W.N. Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 2001, 50 (1-2), 61-80.
3. Wasan, K.M. The role of lymphatic transport in enhancing oral protein and peptide drug delivery. Drug Dev. Ind. Pharm. 2002, 28, 1047-1058.
4. Serajuddin, A.T.M.; Sheen, P.C.; Mufson, D.; Berstein, D.F.; Augustine, M.A. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J. Pharm. Sci. 1988, 77, 414-417.
5. Sheen, P.C.; Kim, E.I.; Petillo, J.J.; Serajuddin, A.T.M. Bioavailability of a poorly water-soluble drug from tablet and solid dispersion in humans. J. Pharm. Sci. 1991, 80, 712-714.
6. Hauss, D.J.; Fogal, S.E.; Ficorilli, J.V.; Price, C.A.; Roy, T.; Jayaraj, A.A.; Keirns, J.J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 1998, 87, 165-169.
7. Holm, R.; Porter, C.J.; Mullertz, A.; Kristensen, H.G.; Charman, W.N. Structured triglycerides vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharm. Res. 2002, 19, 1354-1361.
8. Muranishi, S. Delivery system design for improvement of intestinal absorption of peptide drugs. Yakugaku Zasshi 1997, 117, 394-414.
9. Yanagawa, A.; Iwayama, T.; Saotome, T.; Shoji, Y.; Takano, K.; Oka, H.; Nakagawa, T.; Mizushima, Y. Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres. J. Microencapsul. 1989, 6, 161-164.
10. Sato, H.; Liu, H.X.; Adachi, I.; Ueno, M.; Lemaire, M.; Horikoshi, I. Enhancement of the intestinal absorption of a cyclosporine derivative by milk fat globule membrane. Biol. Pharm. Bull. 1994, 17, 1526-1528.
11. Caliph, S.M.; Charman, W.N.; Porter, C.J. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci. 2000, 89, 1073-1084.
12. Young, S.C.; Hui, D.Y. Pancreatic lipase/ colipase-mediated triacylglycerol hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells. Biochem. J. 1999, 339, 615-620.
13. Bugaut, M.; Carlier, H. Role of intestinal hydrolases, endogenous substrates and chyloportal partition in fat absorption. In Fat Absorption; Kuksis, A., Ed.; CRC Press: Boca Raton, 1987; Vol. 1. 197-232.